CEO SUMMARY: In Dallas, the relatively short-lived lab company known as Med Fusion has a new owner. After seven years, the lab partnership of Baylor Scott and White, US Oncology Network, Texas Oncology, and Pathologists Bio-Medical Laboratories decided to sell their ownership stakes to Quest Diagnostics. The sale comes despite $100 million of capital and
Tag: arup laboratoriesSkip to articles
ARUP Laboratories is a nonprofit national clinical and anatomic pathology reference laboratory, and an enterprise of the University of Utah and its Department of Pathology. Based in Salt Lake City, UT, it was founded in 1984. Currently its Chief Executive Officer is Edgar Braendle, MD, PhD.
With more than 3,000 employees, ARUP Lab offers in excess of 3,000 tests and test combinations, ranging from routine screening tests to highly esoteric molecular and genetic assays.
Rather than competing with its clients for physician office business, ARUP Lab supports clients’ existing test menus by offering highly complex and unique lab tests, with accompanying consultative support, to enhance their abilities to provide laboratory services.
ARUP offers diagnostic laboratory testing services to thousands of clients, including academic hospitals, children’s hospitals, multihospital groups, major commercial laboratories, group purchasing organizations, military and government facilities, and major clinics, in all 50 states. It is the reference lab of choice for more than 50 percent of the nation’s university medical centers, pediatric hospitals, and teaching hospitals.
ARUP’s clients include more than half of the nation’s university teaching hospitals and children’s hospitals, as well as regional hospital networks, multihospital groups, major commercial laboratories, group purchasing organizations, military and government facilities, and major clinics.
ARUP Lab is home to more than 60 individual labs specializing in all aspects of clinical and anatomic pathology. The test menu encompasses more than 3,000 tests, including highly specialized and esoteric tests. Comprehensive testing is offered in the areas of pathology, allergy and immunology, chemistry, cytogenetics, endocrinology, fetal risk assessment, genetics, hematology, hepatitis and HIV, infectious diseases, neurology, oncology, genetics, molecular oncology, anatomic pathology, pediatrics, and pain management, among others.
ARUP Lab performs 99 percent of all testing onsite in one central location, operating 24 hours per day, 7 days a week, and processing an average of 45,000–50,000 specimens of blood, body fluid, and tissue biopsies per day.
ARUP is a CLIA-certified diagnostic lab with more than 25 years of experience successfully supporting clinical trials. ARUP has more than 90 medical experts available for client consultation. These professionals hold faculty appointments at the University of Utah School of Medicine; many participate in care teams at the Huntsman Cancer Hospital and Primary Children’s Hospital.
CEO SUMMARY: Being accredited to this internationally recognized standard for quality and competence communicates to clients and prospective clients that one of the nation’s largest clinical labs is committed to the highest standards of quality. Clients already knew about that commitment but now have definitive proof, ARUP said. Also, lab administrators believed that gaining accreditation
Throughout the profession of laboratory medicine, concern is surfacing following publication of a proposed rule by the Department of Veterans Affairs (VA) that would expand the authority of Advanced Practice Registered Nurses (APRNs) to supervise and perform laboratory testing. This rule would expand APRNs’ authority, currently limited to ordering and interpreting lab tests. In an
CEO SUMMARY: To encourage more students to pursue medical technology (MT) and medical laboratory technician (MLT) degrees, ARUP Laboratories and Weber State University (WSU) are collaborating to promote the distance learning programs offered at WSU. Online students can work any shift and take courses anytime (day, night, or on weekends), thereby making education more accessible
It’s a lawsuit that Quest Diagnostics Incorporated can’t seem to make go away. Last week in California, a federal judge ruled Hunter Laboratories and Surgical Pathology Associates (SPA) can continue to pursue their antitrust lawsuit against Quest Diagnostics. Plaintiffs allege that Quest conspired to monopolize lab testing in California. Hunter Laboratories claimed it was harmed because Quest Diagnostics sold lab tests below cost. SPA claimed it was harmed because Quest had below-cost capitated con- tracts with certain payers.
CEO SUMMARY: Since 2006, the FDA has said it has the authority to regulate lab-developed tests, but it has held off on doing so. Now the agency says it’s time, defining LDTs as being, “designed, manufactured, and used within a single laboratory. LDTs include some genetic tests and tests that are used by healthcare professionals
Saudi Arabia is the second country to embark on the goal of sequencing 100,000 human genomes. Earlier this month, the Saudi Human Genome Program was announced. Funding for the program, expected to take five years, will be provided by the Saudi Arabian national science agency. The first country to declare this goal was the United
CEO SUMMARY: Tasked with cutting $2 million from their lab’s annual operating budget, the lab team at Broward Health System instituted changes that included a lab test formulary and ordering algorithms. In collaboration with physicians, these changes reduced the use of outmoded tests while ensuring that the correct test or blood product was ordered for
CEO SUMMARY: Described by its CEO as “an information company that happens to do laboratory testing,” PeaceHealth Laboratories of Springfield, Oregon, is moving swiftly to develop and deliver value-added services to its client physicians. The lab’s goal is to help referring doctors achieve improved patient outcomes.
HEALTHCARE IS CHANGING RAPIDLY, and perceptive pathologists and laboratory directors
CEO SUMMARY: Cost-cutting is now the prime directive at progressive labs because nearly every laboratory organization in the United States is under sustained financial pressure. This is due to shrinking budgets for hospital labs and more aggressive price-cutting by private payers. Even Obamacare is a factor, because of the Medicare Part B price cuts it